About Reverie Labs
Reverie Labs is a Healthcare company based in Boston (United States) founded in 2017 by Jonah Kallenbach and Ankit Gupta, and was acquired by Ginkgo Bioworks in February 2024. AI-based molecular modeling software is provided for drug design optimization. Reverie Labs has raised $25.03 million across 2 funding rounds from investors including Ginkgo Bioworks, Y Combinator and First Round Capital. The company has 27 employees. Its chief executive, as recorded, is Jonah Kallenbach. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Formation Bio, BigHat and Predictive Oncology; 3 of its 3 listed competitors have raised funding.
Company details
Reverie Labs was founded in 2017 and is headquartered in Boston, United States. Operations center on the application of machine learning to accelerate drug design pipelines within the biotechnology sector. Lead generation and optimization are supported through structure-based predictive models for small molecule potency and ADMEPK properties. Custom model development is also handled to meet specific research needs.
- Headquarters Boston, United States
- Employees 27
- Founders Jonah Kallenbach, Ankit Gupta
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website reverielabs.com
- Social LinkedIn X Facebook
- Acquired by Ginkgo Bioworks (Feb 2024)
- Legal Name Reverie Labs
- Total Equity Funding$25.03M (USD)
in 2 rounds
- Latest Funding Round$25M (USD), Series A
Feb 2021
- InvestorsGinkgo Bioworks
& 4 more
- Employee Count27
- Acquired byGinkgo Bioworks
(Feb 2024)
Funding Insights of Reverie Labs
Reverie Labs has successfully raised a total of $25.03M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.03M
- Total Rounds 2
- Last Round Series A — $25M
- First Round $30,000
(Jun 2017)
- Investors Count 4
All 2 funding rounds of Reverie Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $25M | Series A | – | Ridgeback Capital Management | |
| Jun 2017 | $30,000 | Seed | – | Rough Draft Ventures | – |
5 investors in total: 5 institutional.
Investors in Reverie Labs
Reverie Labs has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Ginkgo Bioworks, Y Combinator and First Round Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
US focused seed and early-stage VC firm | firstround.com | San Francisco, United States | ||
Ridgeback Capital is focused on healthcare and life science investments. | ridgebackcap.com | New York, United States | ||
Micro-venture capital firm investing in multiple sectors | roughdraft.vc | Cambridge, United States | ||
Gene editing-based cultured ingredients are provided for agriculture. | 2008 | ginkgobioworks.com | Boston, United States |
Investor details for Reverie Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Reverie Labs
3 people are tracked at Reverie Labs (3 in leadership); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Jonah Kallenbach | Co-Founder & CEO | Leadership |
Ankit Gupta | Co-Founder & CTO | Leadership |
Valarie Truax | VP, Business Development & Corporate Strategy | Leadership |
Complete people profiles for Reverie Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Reverie Labs
4 dated milestones of Reverie Labs across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Reverie Labs is founded.
- Funding First funding round of $30K.
- Funding Latest funding round, Series A, of $25.0M.
- Exit Acquired by Ginkgo Bioworks.
Competitors of Reverie Labs
Reverie Labs has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, BigHat and Predictive Oncology.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| formation.bio | 2016 | New York, United States | $608.25M | AI-powered drug discovery platform for various diseases | ||
| bighatbio.com | 2019 | San Carlos, United States | $148.41M | Antibody therapies are developed through machine learning and synthetic biology. | ||
| predictive-oncology.com | 2002 | Eagan, United States | $43M | 31 | AI-based platform for cancer diagnostics and precision medicine is utilized. |
Detailed competitors of Reverie Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Reverie Labs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reverie Labs
Complete news archive for Reverie Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reverie Labs
Reverie Labs was founded in 2017.
Reverie Labs is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jonah Kallenbach is the CEO of Reverie Labs, as recorded in our data. They have also founded this company.
Reverie Labs is a funded company, having raised a total of $25.03M across 2 funding rounds to date. The company's 1st funding round was a Seed of $30K, raised on Jun 2017.
Reverie Labs has 27 employees.
Reverie Labs was founded in 2017 and is headquartered in Boston, United States. Operations center on the application of machine learning to accelerate drug design pipelines within the biotechnology sector. Lead generation and optimization are supported through structure-based predictive models for small molecule potency and ADMEPK properties. Custom model development is also handled to meet specific research needs.
Reverie Labs's top competitors include Formation Bio, Predictive Oncology and BigHat.
Reverie Labs has 5 investors. Key investors include Ginkgo Bioworks, Y Combinator, First Round Capital, Ridgeback Capital, and Rough Draft Ventures.
Reverie Labs operates through Reverie Labs.
Yes. Reverie Labs was acquired by Ginkgo Bioworks in February 2024.